Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
1.
Clin Exp Allergy ; 47(9): 1150-1158, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28543872

RESUMO

BACKGROUND: PAI-1 gain-of-function variants promote airway fibrosis and are associated with asthma and with worse lung function in subjects with asthma. OBJECTIVE: We sought to determine whether the association of a gain-of-function polymorphism in plasminogen activator inhibitor-1 (PAI-1) with airway obstruction is modified by asthma status, and whether any genotype effect persists after accounting for common exposures that increase PAI-1 level. METHODS: We studied 2070 Latino children (8-21y) with genotypic and pulmonary function data from the GALA II cohort. We estimated the relationship of the PAI-1 risk allele with FEV1/FVC by multivariate linear regression, stratified by asthma status. We examined the association of the polymorphism with asthma and airway obstruction within asthmatics via multivariate logistic regression. We replicated associations in the SAPPHIRE cohort of African Americans (n=1056). Secondary analysis included the effect of the at-risk polymorphism on postbronchodilator lung function. RESULTS: There was an interaction between asthma status and the PAI-1 polymorphism on FEV1 /FVC (P=.03). The gain-of-function variants, genotypes (AA/AG), were associated with lower FEV1 /FVC in subjects with asthma (ß=-1.25, CI: -2.14,-0.35, P=.006), but not in controls. Subjects with asthma and the AA/AG genotypes had a 5% decrease in FEV1 /FVC (P<.001). In asthmatics, the risk genotype (AA/AG) was associated with a 39% increase in risk of clinically relevant airway obstruction (OR=1.39, CI: 1.01, 1.92, P=.04). These associations persisted after exclusion of factors that increase PAI-1 including tobacco exposure and obesity. CONCLUSIONS AND CLINICAL RELEVANCE: The decrease in the FEV1 /FVC ratio associated with the risk genotype was modified by asthma status. The genotype increased the odds of airway obstruction by 75% within asthmatics only. As exposures known to increase PAI-1 levels did not mitigate this association, PAI-1 may contribute to airway obstruction in the context of chronic asthmatic airway inflammation.


Assuntos
Obstrução das Vias Respiratórias/genética , Obstrução das Vias Respiratórias/metabolismo , Mutação com Ganho de Função , Inibidor 1 de Ativador de Plasminogênio/genética , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Adolescente , Adulto , Obstrução das Vias Respiratórias/epidemiologia , Obstrução das Vias Respiratórias/fisiopatologia , Alelos , Asma Ocupacional/epidemiologia , Asma Ocupacional/genética , Asma Ocupacional/metabolismo , Asma Ocupacional/fisiopatologia , Criança , Estudos de Coortes , Etnicidade , Feminino , Estudos de Associação Genética , Predisposição Genética para Doença , Genótipo , Humanos , Masculino , Razão de Chances , Polimorfismo de Nucleotídeo Único , Testes de Função Respiratória , Adulto Jovem
2.
Mycoses ; 60(4): 244-253, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27910191

RESUMO

Phaeosphaeriaceae is a family in the order Pleosporales containing numerous plant pathogens, endophytes, lichenised fungi, and environmental saprobes. A novel genus, Tintelnotia is introduced containing two species, one of which caused an eye infection and several nail infections in humans. All species of Tintelnotia produce conidia in soft pycnidia with a wide ostiole. The generic type species is T. opuntiae causing necrotic spots on cactus plants. The isolates of the human opportunist T. destructans showed variable susceptibility pattern to a panel of common antifungal agents. The MICs of amphotericin B, voriconazole, posaconazole and itraconazole were 1 µg/mL, complemented by an in vitro MEC of 16 µg/mL against caspofungin; the MIC of terbinafine was 0.125 µg/mL. The latter compound contributed to the successful therapy in the ocular mycosis refractory to standard antifungal therapy, the benefit of terbinafine should be highlighted as a therapeutic option especially in difficult-to-treat fungal keratitis.


Assuntos
Ascomicetos/efeitos dos fármacos , Ascomicetos/isolamento & purificação , Córnea/microbiologia , Infecções Oculares Fúngicas/microbiologia , Unhas/microbiologia , Anfotericina B/farmacologia , Antifúngicos/farmacologia , Ascomicetos/classificação , Ascomicetos/genética , Caspofungina , Equinocandinas/farmacologia , Infecções Oculares Fúngicas/tratamento farmacológico , Feminino , Humanos , Itraconazol/farmacologia , Ceratite/tratamento farmacológico , Lipopeptídeos/farmacologia , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Naftalenos/farmacologia , Naftalenos/uso terapêutico , Filogenia , Terbinafina , Triazóis/farmacologia , Voriconazol/farmacologia
3.
Clin Exp Allergy ; 46(11): 1398-1406, 2016 11.
Artigo em Inglês | MEDLINE | ID: mdl-27238356

RESUMO

BACKGROUND: Younger maternal age at birth is associated with increased risk of asthma in offspring in European descent populations, but has not been studied in Latino populations. OBJECTIVES: We sought to examine the relationship between maternal age at birth and prevalence of asthma in a nationwide study of Latino children. METHODS: We included 3473 Latino children aged 8-21 years (1696 subjects with physician-diagnosed asthma and 1777 healthy controls) from five US centres and Puerto Rico recruited from July 2008 through November 2011. We used multiple logistic regression models to examine the effect of maternal age at birth on asthma in offspring overall and in analyses stratified by ethnic subgroup (Mexican American, Puerto Rican and other Latino). Secondary analyses evaluated the effects of siblings, acculturation and income on this relationship. RESULTS: Maternal age < 20 years was significantly associated with decreased odds of asthma in offspring, independent of other risk factors (OR = 0.73, 95% CI: 0.57-0.93). In subgroup analyses, the protective effect of younger maternal age was observed only in Mexican Americans (OR = 0.53, 95% CI: 0.36, 0.79). In Puerto Ricans, older maternal age was associated with decreased odds of asthma (OR = 0.65, 95% CI: 0.44-0.97). In further stratified models, the protective effect of younger maternal age in Mexican Americans was seen only in children without older siblings (OR = 0.44, 95% CI: 0.23-0.81). CONCLUSION AND CLINICAL RELEVANCE: In contrast to European descent populations, younger maternal age was associated with decreased odds of asthma in offspring in Mexican American women. Asthma is common in urban minority populations but the factors underlying the varying prevalence among different Latino ethnicities in the United States is not well understood. Maternal age represents one factor that may help to explain this variability.


Assuntos
Asma/epidemiologia , Asma/etiologia , Hispânico ou Latino , Idade Materna , Adolescente , Estudos de Casos e Controles , Criança , Feminino , Hispânico ou Latino/estatística & dados numéricos , Humanos , Masculino , Vigilância da População , Fatores de Risco , Estados Unidos/epidemiologia , Adulto Jovem
4.
Gene Ther ; 22(10): 822-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26043872

RESUMO

Targeted knockout of genes in primary human cells using CRISPR-Cas9-mediated genome-editing represents a powerful approach to study gene function and to discern molecular mechanisms underlying complex human diseases. We used lentiviral delivery of CRISPR-Cas9 machinery and conditional reprogramming culture methods to knockout the MUC18 gene in human primary nasal airway epithelial cells (AECs). Massively parallel sequencing technology was used to confirm that the genome of essentially all cells in the edited AEC populations contained coding region insertions and deletions (indels). Correspondingly, we found mRNA expression of MUC18 was greatly reduced and protein expression was absent. Characterization of MUC18 knockout cell populations stimulated with TLR2, 3 and 4 agonists revealed that IL-8 (a proinflammatory chemokine) responses of AECs were greatly reduced in the absence of functional MUC18 protein. Our results show the feasibility of CRISPR-Cas9-mediated gene knockouts in AEC culture (both submerged and polarized), and suggest a proinflammatory role for MUC18 in airway epithelial response to bacterial and viral stimuli.


Assuntos
Vetores Genéticos , Lentivirus , Mucosa Respiratória/metabolismo , Antígeno CD146/genética , Antígeno CD146/imunologia , Antígeno CD146/metabolismo , Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas , Expressão Gênica , Técnicas de Inativação de Genes , Humanos , Inflamação/genética , Cultura Primária de Células , Mucosa Respiratória/imunologia
5.
J Cyst Fibros ; 14(2): 237-41, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25595044

RESUMO

OBJECTIVE: Detection of hyphomycetes of the Scedosporium apiospermum complex and Lomentospora prolificans (Sac-Lp) is not yet standardized. Prevalence rates in patients with cystic fibrosis (CF) and the resistance pattern of these pathogens in Germany are unknown. METHODS: In a one-year prospective study 11 laboratories used a selective medium for isolation of Sac-Lp, examining >11,600 respiratory samples from 2346 patients with CF. Isolates were identified by molecular methods and tested for susceptibility to antifungal drugs. RESULTS: The prevalence of Sac-Lp in patients with CF in Germany varied from 0.0 to 10.5% (mean: 3.1%) among the clinical centres. The benefit of the selective medium SceSel(+) compared to standard media for fungi was documented for >5000 samples. High antifungal resistance was detected in the S. apiospermum complex, and the multiresistance of L. prolificans was confirmed. CONCLUSION: Microbiology laboratories should be aware of these resistant species in patients with CF and consider using a selective medium.


Assuntos
Antifúngicos/farmacologia , Meios de Cultura/farmacologia , Fibrose Cística , Micoses , Scedosporium , Adulto , Fibrose Cística/complicações , Fibrose Cística/epidemiologia , Fibrose Cística/microbiologia , Farmacorresistência Fúngica , Feminino , Alemanha/epidemiologia , Humanos , Masculino , Testes de Sensibilidade Microbiana/métodos , Micoses/diagnóstico , Micoses/epidemiologia , Micoses/etiologia , Micoses/microbiologia , Prevalência , Estudos Prospectivos , Scedosporium/classificação , Scedosporium/efeitos dos fármacos , Scedosporium/isolamento & purificação
6.
Pharmacogenomics J ; 14(4): 365-71, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24418963

RESUMO

Inhaled short-acting beta-agonist (SABA) medication is commonly used in asthma patients to rapidly reverse airway obstruction and improve acute symptoms. We performed a genome-wide association study of SABA medication response using gene-based association tests. A linear mixed model approach was first used for single-nucleotide polymorphism associations, and the results were later combined using GATES to generate gene-based associations. Our results identified SPATA13-AS1 as being significantly associated with SABA bronchodilator response in 328 healthy African Americans. In replication, this gene was associated with SABA response among the two separate groups of African Americans with asthma (n=1073, P=0.011 and n=1968, P=0.014), 149 healthy African Americans (P=0.003) and 556 European Americans with asthma (P=0.041). SPATA13-AS1 was also associated with longitudinal SABA medication usage in the two separate groups of African Americans with asthma (n=658, P=0.047 and n=1968, P=0.025). Future studies are needed to delineate the precise mechanism by which SPATA13-AS1 may influence SABA response.


Assuntos
Agonistas Adrenérgicos beta/administração & dosagem , Asma/tratamento farmacológico , Estudo de Associação Genômica Ampla , Fatores de Troca do Nucleotídeo Guanina/genética , Farmacogenética , Polimorfismo de Nucleotídeo Único , Administração por Inalação , Adulto , Negro ou Afro-Americano , Asma/genética , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Grupos Populacionais
7.
Ophthalmic Res ; 48(4): 171-6, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22710976

RESUMO

PURPOSE: To report a series of 3 patients with soft contact lens-related Fusarium keratitis. Two of them were treated with the antiamoebic polyhexamethylene biguanide 0.02% (PHMB) in combination with antifungal drugs, and 1 patient was treated with PHMB as sole antifungal regimen. METHODS: Chart review of 3 patients treated with PHMB in Fusarium keratitis. Two of them were refractory to the commonly used therapy. The antifungal power of PHMB and propamidine isethionate was tested against the patients' isolates as well as against the clinical isolates from another 9 patients with ocular mould infections. RESULTS: An excellent outcome could be achieved in 2 patients with Fusarium solani keratitis refractory to common antifungal treatment by the additional use of PHMB 0.02%. In another patient PHMB alone was sufficient to resolve Fusarium proliferatum infection. The drug was well tolerated. In all patients repeated abrasion was done for better penetration of the drugs. PHMB revealed a marked in vitro antifungal activity for the three Fusarium isolates as well as for another 9 isolates of ocular infections from other patients including also the genera Scedosporium, Aspergillus and Rhizopus giving minimal inhibitory concentrations ranging from 1.56 to 3.12 µg/ml. CONCLUSIONS: Fusarium keratitis is a severe ocular infection. We report on the use of PHMB in 3 patients given additionally or as sole antifungal drug. We emphasize the benefit of PHMB 0.02% in Fusarium keratitis which might be considered as a therapeutic option especially in cases refractory to common antifungal therapy and possibly in keratitis due to other fungi.


Assuntos
Antifúngicos/uso terapêutico , Biguanidas/uso terapêutico , Úlcera da Córnea/tratamento farmacológico , Desinfetantes/uso terapêutico , Infecções Oculares Fúngicas/tratamento farmacológico , Fusariose/tratamento farmacológico , Fusarium/isolamento & purificação , Adulto , Antifúngicos/farmacologia , Benzamidinas/farmacologia , Benzamidinas/uso terapêutico , Biguanidas/farmacologia , Lentes de Contato Hidrofílicas/microbiologia , Úlcera da Córnea/microbiologia , Desinfetantes/farmacologia , Quimioterapia Combinada , Infecções Oculares Fúngicas/microbiologia , Feminino , Fungos/efeitos dos fármacos , Fusariose/microbiologia , Humanos , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Natamicina/farmacologia , Natamicina/uso terapêutico , Pirimidinas/farmacologia , Pirimidinas/uso terapêutico , Triazóis/farmacologia , Triazóis/uso terapêutico , Voriconazol
8.
Hum Genet ; 131(7): 1105-14, 2012 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22200767

RESUMO

Two primary chitinases have been identified in humans--acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1). Mammalian chitinases have been observed to affect the host's immune response. The aim of this study was to test for association between genetic variation in the chitinases and phenotypes related to chronic obstructive pulmonary disease (COPD). Polymorphisms in the chitinase genes were selected based on previous associations with respiratory diseases. Polymorphisms that were associated with lung function level or rate of decline in the Lung Health Study (LHS) cohort were analyzed for association with COPD affection status in four other COPD case-control populations. Chitinase activity and protein levels were also related to genotypes. In the caucasian LHS population, the baseline forced expiratory volume in one second (FEV(1)) was significantly different between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism. Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes. For CHIT1 rs2494303, a significant association was observed between rate of decline in FEV(1) and the different genotypes. In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were associated with rate of decline in FEV(1). Although a significant effect of chitinase gene alleles was found on lung function level and decline in the LHS, we were unable to replicate the associations with COPD affection status in the other COPD study groups.


Assuntos
Quitinases/genética , Volume Expiratório Forçado , Polimorfismo de Nucleotídeo Único , Doença Pulmonar Obstrutiva Crônica/genética , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Idoso , Líquido da Lavagem Broncoalveolar/química , Estudos de Casos e Controles , Quitinases/metabolismo , Feminino , Variação Genética , Genótipo , Humanos , Pulmão/metabolismo , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Fenótipo , Doença Pulmonar Obstrutiva Crônica/enzimologia , Fenômenos Fisiológicos Respiratórios , Fumar
9.
Med Mycol ; 48(7): 1000-4, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20513171

RESUMO

This report describes an uncommon case of cryptococcosis in an apparently immunocompetent cat caused by Cryptococcus magnus. An amputation of the complete left foreleg and excision of the ipsilateral cervical lymph node were performed in a young-adult male Domestic Shorthair cat due to suspicion of a tumor. Granulomatous dermatitis, panniculitis, myositis, and lymphadenitis were diagnosed histologically. Intralesional, numerous round-to-ovoid yeast cells showing no capsule were detected within macrophages using special staining methods. The tissue material cultured on Sabouraud's glucose agar at 26°C yielded abundant growth of yeast colonies. Morphological, physiological, and molecular analyses of the yeasts demonstrated that the fungus was C. magnus. Response to treatment with fluconazole was fast and effective, and one year after the end of the therapy no further clinical signs of infection were observed.


Assuntos
Doenças do Gato/microbiologia , Criptococose/veterinária , Cryptococcus/isolamento & purificação , Animais , Antifúngicos/uso terapêutico , Sequência de Bases , Doenças do Gato/tratamento farmacológico , Doenças do Gato/patologia , Gatos , Criptococose/tratamento farmacológico , Criptococose/microbiologia , Criptococose/patologia , Cryptococcus/genética , DNA Intergênico/genética , Fluconazol/uso terapêutico , Masculino , Dados de Sequência Molecular , RNA Fúngico/genética , RNA Ribossômico/genética
10.
Clin Exp Allergy ; 40(4): 582-9, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20067482

RESUMO

BACKGROUND: Leukotrienes play an important role in allergic and inflammatory diseases, but reports on the involvement of arachidonate 5-lipoxygenase-activating protein (ALOX5AP) and leukotriene A(4) hydrolase (LTA4H) in asthma have been inconclusive. OBJECTIVE: To determine whether polymorphisms in ALOX5AP and LTA4H genes are risk factors for asthma in two different Latino groups: Mexicans and Puerto Ricans. METHODS: The LTA4H gene was sequenced in individuals from both groups to identify novel polymorphisms. Single-nucleotide polymorphisms (SNPs) in the ALOX5AP and LTA4H genes were analysed for associations with asthma and asthma-related phenotypes in 687 parent-child trios of Mexican and Puerto Rican origin. RESULTS: In LTA4H, five previously unknown polymorphisms were identified. Two SNPs within LTA4H (rs17525488 and rs2540493) were protective for asthma in Latinos (P=0.007 and 0.05, respectively). Among the Mexican patients, LTA4H polymorphisms were associated with baseline lung function and IgE levels. For ALOX5AP, the minor allele at SNP rs10507391 was associated with protection from asthma (odds ratio=0.78, P=0.02) and baseline lung function (P=0.018) in Puerto Ricans. A gene-gene interaction was identified between LTA4H (rs17525488) and ALOX5AP (rs10507391), (P=0.003, in the combined sample). CONCLUSION: Our results support the role of LTA4H and ALOX5AP variants as risk factors for asthma in Latino populations.


Assuntos
Asma/genética , Proteínas de Transporte/genética , Epóxido Hidrolases/genética , Predisposição Genética para Doença , Hispânico ou Latino/genética , Proteínas de Membrana/genética , Proteínas Ativadoras de 5-Lipoxigenase , Adolescente , Alelos , Asma/etnologia , Asma/fisiopatologia , Proteínas de Transporte/metabolismo , Criança , Epóxido Hidrolases/metabolismo , Feminino , Frequência do Gene , Estudos de Associação Genética , Humanos , Masculino , Proteínas de Membrana/metabolismo , Americanos Mexicanos , Polimorfismo de Nucleotídeo Único , Fatores de Risco , Adulto Jovem
11.
Med Mycol ; 47(4): 351-8, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19301173

RESUMO

Scedosporium prolificans is one of the most life-threatening fungal opportunistic pathogens due to its high resistance to common systemic antifungal agents. While a close relative of Pseudallescheria boydii, S. prolificans has a more limited geographic range being primarily found in Australia, USA and Spain. Infections have also been reported from several other European countries and from Chile. Twenty patients with Scedosporium prolificans infection or colonization from August 1993 to May 2007 were retrospectively reviewed in Germany. They had all been identified at or reported to the Reference Laboratory for Pseudallescheria/Scedosporium spp. in Berlin. Twelve of 13 patients with haematological disorders and/or on immunosuppressive therapy developed a fatal invasive scedosporiosis. Colonization of the respiratory tract was reported for one patient after heart-lung-transplantation, all six patients with cystic fibrosis and one with chronic sinusitis. Molecular studies of the S. prolificans isolates confirmed that parts of the 18S, the Internal Transcribed Spacer (ITS) regions and the D1/D2 domain of the 28S region of rDNA are monomorphic. However, sequencing of parts of the translation elongation factor EF1-alpha (EF-1alpha) and the chitin synthase (CHS-1) genes revealed the presence of three and two distinct genotypes, respectively. Two informative mutations were found in EF-1alpha and a single nucleotide exchange in the CHS-1 gene.


Assuntos
Micoses/epidemiologia , Micoses/microbiologia , Scedosporium/isolamento & purificação , Adolescente , Adulto , Criança , Quitina Sintase/genética , DNA Fúngico/química , DNA Fúngico/genética , DNA Ribossômico/química , DNA Ribossômico/genética , DNA Espaçador Ribossômico/química , DNA Espaçador Ribossômico/genética , Feminino , Proteínas Fúngicas/genética , Alemanha/epidemiologia , Neoplasias Hematológicas/complicações , Humanos , Hospedeiro Imunocomprometido , Imunossupressores/efeitos adversos , Masculino , Pessoa de Meia-Idade , Fator 1 de Elongação de Peptídeos/genética , Filogenia , Polimorfismo Genético , RNA Ribossômico 28S/genética , Análise de Sequência de DNA , Adulto Jovem
12.
Transpl Infect Dis ; 10(4): 290-3, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18194367

RESUMO

Fusarium infections are associated with high mortality after allogeneic stem cell transplantation. We report on successful treatment of a disseminated cutaneous Fusarium proliferatum infection using liposomal amphotericin B and terbinafine. In vitro susceptibility tests of antifungal drugs suggest that terbinafine is a potent additional antifungal drug for disseminated cutaneous fusariosis.


Assuntos
Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Dermatomicoses/tratamento farmacológico , Naftalenos/uso terapêutico , Transplante de Células-Tronco/efeitos adversos , Transplante Homólogo/efeitos adversos , Dermatomicoses/microbiologia , Quimioterapia Combinada , Feminino , Fusarium/efeitos dos fármacos , Humanos , Pessoa de Meia-Idade , Neutropenia/complicações , Terapia de Salvação , Terbinafina , Resultado do Tratamento
13.
Med Mycol ; 46(1): 79-83, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17852716

RESUMO

Candidal vertebral osteomyelitis represents an extremely rare invasive mycosis and can be difficult to treat due to poor drug penetration into bony tissue. We report on a case of vertebral osteomyelitis caused by Candida krusei in a patient who had neutropenia as a result of chemotherapy for acute myelogenous leukaemia. The patient received prophylactic liposomal amphotericin B during chemotherapy but became febrile and experienced severe lumbar pain. Magnetic resonance imaging revealed vertebral osteochondrosis. C. krusei was recovered from blood cultures and voriconazole monotherapy was initiated but proved unsuccessful. The patient was then started on caspofungin monotherapy, which was discontinued after Candida krusei was no longer recoverable from blood cultures. However, as lumbar pain increased and spinal biopsy confirmed the presence of Candida krusei, caspofungin therapy was resumed. Oral posaconazole was added to the regimen when the patient did not improve after 30 days of caspofungin therapy. Combined antimycotic therapy resulted in a successful outcome.


Assuntos
Candida/patogenicidade , Candidíase/tratamento farmacológico , Equinocandinas/uso terapêutico , Vértebras Lombares/microbiologia , Triazóis/uso terapêutico , Antifúngicos/uso terapêutico , Candidíase/diagnóstico , Candidíase/microbiologia , Caspofungina , Quimioterapia Combinada , Humanos , Lipopeptídeos , Vértebras Lombares/patologia , Imageamento por Ressonância Magnética , Masculino , Pessoa de Meia-Idade , Osteomielite/diagnóstico , Osteomielite/tratamento farmacológico , Osteomielite/microbiologia
14.
Med Mycol ; 45(5): 385-93, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17654264

RESUMO

The ribosomal Internal Transcribed Spacer (ITS) regions of the two recognized species of Coccidioides were studied using a reference set of strains that had been previously identified with species defining microsatellite polymorphisms. Unambiguous identification of the two species proved to be possible by amplifying and sequencing the ITS region. PCR-reactions are sensitive to amplification conditions requiring their careful optimization. Stable amplification and sequencing was achieved with primers ITS3 and 4, enabling species diagnosis. Alternatively, Restriction Fragment Length Polymorphism (RFLP) of the entire ITS region using an annealing temperature of 52 degrees C with the restriction enzymes BsrI and XcmI can also distinguish the species. Three strains typifying the species, Glenospora meteuropaea, G. metamericana and Geotrichum louisianoideum, were analyzed and found to be conspecific with C. posadasii. Although these species have nomenclatural priority over C. posadasii, the latter will be proposed for conservation as it has been included in the US select agent list. In addition, Coccidioides immitis is neotypified in this report. Results of antifungal susceptibility testing did not reveal differences between the two species.


Assuntos
Coccidioides/classificação , Coccidioidomicose/diagnóstico , DNA Espaçador Ribossômico/análise , Marcadores Genéticos , Antifúngicos/farmacologia , Coccidioides/efeitos dos fármacos , Coccidioides/genética , Coccidioidomicose/microbiologia , Primers do DNA , DNA Fúngico/análise , DNA Fúngico/genética , DNA Fúngico/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Técnicas de Tipagem Micológica , Polimorfismo de Fragmento de Restrição , Especificidade da Espécie
15.
Pediatr Blood Cancer ; 49(6): 858-61, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16429409

RESUMO

Fungal infections are a major cause of morbidity and mortality in patients during chemotherapeutic treatments and malignant hematologic disease. We present a case of a double fungal infection with disseminated Acremonium strictum (A. strictum) and pulmonary Aspergillus fumigatus (A. fumigatus) and its rapid clinical course. A 17-year-old boy with prolonged neutropenia developed a disseminated fungal infection during induction chemotherapy of his acute lymphoblastic leukemia. The infection was rapidly lethal despite neutrophil recovery and early antifungal combination therapy with amphotericin B and caspofungin. Since there are only a few reports about invasive Acremonium infections, we present this case with regard to differences in the clinic pathologic features of Aspergillosis and other opportunistic fungal infections due to Fusarium or Acremonium species.


Assuntos
Acremonium , Aspergilose/patologia , Aspergillus fumigatus , Linfoma de Burkitt/patologia , Neutropenia/patologia , Adolescente , Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Aspergilose/tratamento farmacológico , Aspergilose/etiologia , Aspergilose/microbiologia , Linfoma de Burkitt/complicações , Linfoma de Burkitt/tratamento farmacológico , Linfoma de Burkitt/microbiologia , Caspofungina , Equinocandinas , Evolução Fatal , Humanos , Lipopeptídeos , Masculino , Neutropenia/tratamento farmacológico , Neutropenia/etiologia , Neutropenia/microbiologia , Peptídeos Cíclicos/administração & dosagem
16.
Hautarzt ; 55(12): 1137-42, 2004 Dec.
Artigo em Alemão | MEDLINE | ID: mdl-15448927

RESUMO

Localized skin infections caused by the pigmented fungi of the genus Alternaria are being increasingly observed. In the past, primarily patients receiving long-term glucocorticoid therapy were likely to have this mycosis, which is commonly traumatic, but now it is frequently encountered in organ transplantation patients. Possible therapeutic options and differential diagnosis are discussed by means of two case reports--a female renal transplant patient infected by A. alternata and a patient with iatrogenic Cushing syndrome infected by A. infectoria. Histopathological differentiation from other fungal infections may be difficult but is of therapeutic and prognostic significance. Finding short hyphae in tissue sections is an important clue. Since A. infectoria shows little conidial growth in culture, rDNA ITS sequencing offers another diagnostic possibility. Therapy has not yet been standardized. Along with surgical intervention, systemic itraconazole is the usual choice.


Assuntos
Alternaria/isolamento & purificação , Dermatomicoses/diagnóstico , Dermatomicoses/terapia , Itraconazol/uso terapêutico , Idoso , Alternaria/genética , Antifúngicos/uso terapêutico , Dermatomicoses/microbiologia , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Guias de Prática Clínica como Assunto , Padrões de Prática Médica , Prognóstico , Resultado do Tratamento
17.
Ann Hematol ; 83(6): 394-7, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-14648020

RESUMO

A case of disseminated infection with Fusarium oxysporum following chemotherapy of acute myelogenous leukemia is reported. Antifungal treatment was successful with a 13-day course of oral terbinafine 250 mg t.i.d. in combination with amphotericin B deoxycholate 1.0-1.5 mg/kg qd and subsequently intravenous liposomal amphotericin B 5 mg/kg qd. Preceding monotherapy with amphotericin B deoxycholate 1.0-1.5 mg/kg qd had not stopped the progression of infection. The combination therapy described here represents a novel approach to the treatment of Fusarium spp. in the immunocompromised host in whom Fusarium spp. are known to cause disseminated infection with high mortality.


Assuntos
Anfotericina B/administração & dosagem , Antifúngicos/administração & dosagem , Dermatomicoses/tratamento farmacológico , Fusarium , Naftalenos/administração & dosagem , Dermatomicoses/sangue , Dermatomicoses/imunologia , Dermatomicoses/patologia , Quimioterapia Combinada , Humanos , Hospedeiro Imunocomprometido , Leucemia Mieloide Aguda/sangue , Leucemia Mieloide Aguda/microbiologia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Naftalenos/sangue , Neutropenia/tratamento farmacológico , Neutropenia/patologia , Terbinafina , Resultado do Tratamento
18.
Biologicals ; 29(2): 59-66, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11580210

RESUMO

Different procedures are available to inactivate bacteria and fungi, including their spores, as well as viruses in human bone transplants. The most efficient methods are considered to be gamma irradiation and thermal inactivation as well as chemical sterilization methods like the peracetic acid-ethanol treatment (PES). Following national and international standards or draft standards, the antimicrobial effectiveness of this procedure was evaluated. Due to the standardizable size as well as the clinical relevance, defatted human spongiosa cuboids (15x15x15 mm) served as model system. After treatment with PES for 2 and 4 hours, respectively, the titre of living micro-organisms was determined in the supernatant and the cuboid. A reduction in the titre of viable micro-organisms below the detection level (reduction factor >5 log10) was already achieved after an incubation time of 2 hours (Staphylococcus aureus, Enterococcus faecium, Pseudomonas aeruginosa, Bacillus subtilis, Clostridium sporogenes, Mycobacterium terrae, Candida albicans as well as spores of Bacillus subtilis). No viable micro-organisms could be detected in any of the PES-treated test cuboids. Spores of Aspergillus niger were also completely inactivated. The PES procedure proved to be a reliable method for the sterilization of human bone transplants derived from spongiosa.


Assuntos
Transplante Ósseo/métodos , Esterilização/métodos , Bactérias/efeitos dos fármacos , Osso e Ossos/microbiologia , Etanol , Fungos/efeitos dos fármacos , Humanos , Técnicas In Vitro , Ácido Peracético , Esporos Fúngicos/efeitos dos fármacos , Esterilização/normas , Transplante Homólogo
19.
Bone Marrow Transplant ; 28(9): 899-901, 2001 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11781653

RESUMO

Systemic mycosis is among the most feared opportunistic infections in the immunocompromised host. Difficulty and delay in diagnosis and treatment often result in poor outcomes. In this communication a metastatically spreading form of subcutaneous aspergillosis developed in a patient with a history of allogeneic stem cell transplantation for relapsed Hodgkin's lymphoma. Strikingly, necrotizing cutaneous papules or ulcerating lesions were absent. Diagnosis was accomplished after excision of a clinically non-suggestive subcutaneous nodule. Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities. This case report describes a novel form of aspergillosis and underlines the need for an aggressive diagnostic approach in severely immunocompromised patients.


Assuntos
Aspergilose/patologia , Desoxicitidina/análogos & derivados , Transplante de Células-Tronco Hematopoéticas , Doença de Hodgkin/complicações , Infecções Oportunistas/patologia , Adulto , Anfotericina B/uso terapêutico , Antifúngicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Aspergilose/diagnóstico , Aspergilose/tratamento farmacológico , Aspergilose/etiologia , Bleomicina/administração & dosagem , Carmustina/administração & dosagem , Terapia Combinada , Ciclofosfamida/administração & dosagem , Citarabina/administração & dosagem , Dacarbazina/administração & dosagem , Desoxicitidina/administração & dosagem , Dexametasona/administração & dosagem , Doxorrubicina/administração & dosagem , Etoposídeo/administração & dosagem , Evolução Fatal , Doença de Hodgkin/tratamento farmacológico , Doença de Hodgkin/radioterapia , Doença de Hodgkin/terapia , Humanos , Hospedeiro Imunocomprometido , Infecções por Klebsiella/complicações , Infecções por Klebsiella/tratamento farmacológico , Klebsiella pneumoniae/isolamento & purificação , Pneumopatias Fúngicas/diagnóstico , Pneumopatias Fúngicas/tratamento farmacológico , Pneumopatias Fúngicas/etiologia , Masculino , Melfalan/administração & dosagem , Recidiva Local de Neoplasia , Infecções Oportunistas/diagnóstico , Infecções Oportunistas/tratamento farmacológico , Infecções Oportunistas/etiologia , Pneumonia Bacteriana/complicações , Pneumonia Bacteriana/tratamento farmacológico , Pneumonia por Pneumocystis/complicações , Pneumonia por Pneumocystis/tratamento farmacológico , Prednisona/administração & dosagem , Procarbazina/administração & dosagem , Terapia de Salvação , Pele , Transplante Homólogo , Vimblastina/administração & dosagem , Vincristina/administração & dosagem , Gencitabina
20.
J Clin Microbiol ; 38(10): 3696-704, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11015386

RESUMO

Candida dubliniensis is often found in mixed culture with C. albicans, but its recognition is hampered as the color of its colonies in primary culture on CHROMagar Candida varies. Furthermore, definite identification of C. dubliniensis is difficult to achieve, time-consuming, and expensive. Therefore, a method to discriminate between these two closely related yeast species by fatty acid methyl ester (FAME) analysis using gas-liquid chromatography (Sherlock Microbial Identification System [MIS]; MIDI, Inc., Newark, Del.) was developed. Although the chromatograms of these two species revealed no obvious differences when applying FAME analysis, a new library (CADLIB) was successfully created using Sherlock Library Generation Software (MIDI). The amount and frequency of FAME was analyzed using library training files (n = 10 for each species), preferentially those comprising reference strains. For testing the performance of the CADLIB, clinical isolates genetically assigned to the respective species (C. albicans, n = 32; C. dubliniensis, n = 28) were chromatographically analyzed. For each isolate tested, MIS computed a similarity index (SI) indicating a hierarchy of possible strain fits. When using the newly created library CADLIB, the SIs for C. albicans and C. dubliniensis ranged from 0.11 to 0.96 and 0.53 to 0. 93 (for all but one), respectively. Only three isolates of C. albicans (9.4%) were misidentified as C. dubliniensis, whereas all isolates of C. dubliniensis were correctly identified. Resulting differentiation accuracy was 90.6% for C. albicans and 100% for C. dubliniensis. Cluster analysis and principal component analysis of the resulting FAME profiles showed two clearly distinguishable clusters matching up with two assigned species for the strains tested. Thus, the created library proved to be well suited to discriminate between these two species.


Assuntos
Candida albicans/classificação , Candida/classificação , Candidíase/microbiologia , Bases de Dados como Assunto , Infecções Oportunistas Relacionadas com a AIDS/microbiologia , Candida/isolamento & purificação , Candida/fisiologia , Candida albicans/isolamento & purificação , Candida albicans/fisiologia , Cromatografia Gasosa/métodos , Ácidos Graxos/metabolismo , Feminino , Humanos , Filogenia , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...